198 related articles for article (PubMed ID: 37667176)
21. Interactive bioinformatics analysis for the screening of hub genes and molecular docking of phytochemicals present in kitchen spices to inhibit CDK1 in cervical cancer.
Vaghasia H; Sakaria S; Prajapati J; Saraf M; Rawal RM
Comput Biol Med; 2022 Oct; 149():105994. PubMed ID: 36103746
[TBL] [Abstract][Full Text] [Related]
22. Protein kinase Cepsilon interacts with Bax and promotes survival of human prostate cancer cells.
McJilton MA; Van Sikes C; Wescott GG; Wu D; Foreman TL; Gregory CW; Weidner DA; Harris Ford O; Morgan Lasater A; Mohler JL; Terrian DM
Oncogene; 2003 Sep; 22(39):7958-68. PubMed ID: 12970744
[TBL] [Abstract][Full Text] [Related]
23. Genetic deletion of TNFα inhibits ultraviolet radiation-induced development of cutaneous squamous cell carcinomas in PKCε transgenic mice via inhibition of cell survival signals.
Singh A; Singh A; Bauer SJ; Wheeler DL; Havighurst TC; Kim K; Verma AK
Carcinogenesis; 2016 Jan; 37(1):72-80. PubMed ID: 26586792
[TBL] [Abstract][Full Text] [Related]
24. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies.
Bilal MS; Ejaz SA; Zargar S; Akhtar N; Wani TA; Riaz N; Aborode AT; Siddique F; Altwaijry N; Alkahtani HM; Umar HI
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358960
[TBL] [Abstract][Full Text] [Related]
25. Activation of nuclear factor κB (NF-κB) in prostate cancer is mediated by protein kinase C epsilon (PKCepsilon).
Garg R; Blando J; Perez CJ; Wang H; Benavides FJ; Kazanietz MG
J Biol Chem; 2012 Oct; 287(44):37570-82. PubMed ID: 22955280
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia-induced down-modulation of PKCepsilon promotes trail-mediated apoptosis of tumor cells.
Gobbi G; Masselli E; Micheloni C; Nouvenne A; Russo D; Santi P; Matteucci A; Cocco L; Vitale M; Mirandola P
Int J Oncol; 2010 Sep; 37(3):719-29. PubMed ID: 20664941
[TBL] [Abstract][Full Text] [Related]
27. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells.
Bourguignon LY; Spevak CC; Wong G; Xia W; Gilad E
J Biol Chem; 2009 Sep; 284(39):26533-46. PubMed ID: 19633292
[TBL] [Abstract][Full Text] [Related]
28. Diverse roles for protein kinase C delta and protein kinase C epsilon in the generation of high-fat-diet-induced glucose intolerance in mice: regulation of lipogenesis by protein kinase C delta.
Frangioudakis G; Burchfield JG; Narasimhan S; Cooney GJ; Leitges M; Biden TJ; Schmitz-Peiffer C
Diabetologia; 2009 Dec; 52(12):2616-20. PubMed ID: 19809797
[TBL] [Abstract][Full Text] [Related]
29. Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach.
Qi Y; Lai YL; Shen PC; Chen FH; Lin LJ; Wu HH; Peng PH; Hsu KW; Cheng WC
Sci Rep; 2020 Dec; 10(1):22270. PubMed ID: 33335254
[TBL] [Abstract][Full Text] [Related]
30. PKCε contributes to lipid-induced insulin resistance through cross talk with p70S6K and through previously unknown regulators of insulin signaling.
Gassaway BM; Petersen MC; Surovtseva YV; Barber KW; Sheetz JB; Aerni HR; Merkel JS; Samuel VT; Shulman GI; Rinehart J
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8996-E9005. PubMed ID: 30181290
[TBL] [Abstract][Full Text] [Related]
31. miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition.
El Bezawy R; Tinelli S; Tortoreto M; Doldi V; Zuco V; Folini M; Stucchi C; Rancati T; Valdagni R; Gandellini P; Zaffaroni N
J Exp Clin Cancer Res; 2019 Feb; 38(1):51. PubMed ID: 30717752
[TBL] [Abstract][Full Text] [Related]
32. Multitargeted inhibitory effect of Mitoxantrone 2HCl on cervical cancer cell cycle regulatory proteins: a multitargeted docking-based MM\GBSA and MD simulation study.
Alshehri MA; Asiri SA; Alzahrani A; Alazragi RS; Alqahtani LS; Alqosaibi AI; Alnamshan MM; Alam Q; Rafeeq MM
Med Oncol; 2023 Oct; 40(11):337. PubMed ID: 37864019
[TBL] [Abstract][Full Text] [Related]
33. Distinctive requirement of PKCε in the control of Rho GTPases in epithelial and mesenchymally transformed lung cancer cells.
Casado-Medrano V; Barrio-Real L; Wang A; Cooke M; Lopez-Haber C; Kazanietz MG
Oncogene; 2019 Jul; 38(27):5396-5412. PubMed ID: 30923343
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II activates p44/42 MAP kinase partly through PKCepsilon in H295R cells.
Lehoux JG; Lefebvre A
Mol Cell Endocrinol; 2007 Feb; 265-266():121-5. PubMed ID: 17215072
[TBL] [Abstract][Full Text] [Related]
35. Structure of the C2 domain from novel protein kinase Cepsilon. A membrane binding model for Ca(2+)-independent C2 domains.
Ochoa WF; Garcia-Garcia J; Fita I; Corbalan-Garcia S; Verdaguer N; Gomez-Fernandez JC
J Mol Biol; 2001 Aug; 311(4):837-49. PubMed ID: 11518534
[TBL] [Abstract][Full Text] [Related]
36. Oncogene PKCε controls INrf2-Nrf2 interaction in normal and cancer cells through phosphorylation of INrf2.
Niture SK; Gnatt A; Jaiswal AK
J Cell Sci; 2013 Dec; 126(Pt 24):5657-69. PubMed ID: 24127568
[TBL] [Abstract][Full Text] [Related]
37. Formation of protein kinase C(epsilon)-Lck signaling modules confers cardioprotection.
Ping P; Song C; Zhang J; Guo Y; Cao X; Li RC; Wu W; Vondriska TM; Pass JM; Tang XL; Pierce WM; Bolli R
J Clin Invest; 2002 Feb; 109(4):499-507. PubMed ID: 11854322
[TBL] [Abstract][Full Text] [Related]
38. Identification of an inactivating cysteine switch in protein kinase Cepsilon, a rational target for the design of protein kinase Cepsilon-inhibitory cancer therapeutics.
Chu F; Koomen JM; Kobayashi R; O'Brian CA
Cancer Res; 2005 Nov; 65(22):10478-85. PubMed ID: 16288040
[TBL] [Abstract][Full Text] [Related]
39. Chronic prenatal hypoxia induces epigenetic programming of PKC{epsilon} gene repression in rat hearts.
Patterson AJ; Chen M; Xue Q; Xiao D; Zhang L
Circ Res; 2010 Aug; 107(3):365-73. PubMed ID: 20538683
[TBL] [Abstract][Full Text] [Related]
40. PKCepsilon overexpression, irrespective of genetic background, sensitizes skin to UVR-induced development of squamous-cell carcinomas.
Sand JM; Aziz MH; Dreckschmidt NE; Havighurst TC; Kim K; Oberley TD; Verma AK
J Invest Dermatol; 2010 Jan; 130(1):270-7. PubMed ID: 19626035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
